Table 5.
Hazards of discharge related to antiviral treatment timing
| Overall (N = 201) | Vaccinated (N = 106) | Unvaccinated (N = 95) | ||||
|---|---|---|---|---|---|---|
| Predictors | Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value |
| Antiviral treatment | 1.1 (0.8–1.5) | 0.44 | 1.6 (1.0–2.4) | 0.04 | 0.9 (0.5–1.4) | 0.52 |
| Frailty score | 0.5 (0.3–1.0) | 0.04 | 0.6 (0.3–1.3) | 0.17 | 0.5 (0.2–1.2) | 0.11 |
| Total visits (tertiles) | ||||||
| Tertile 0 | Ref | Ref | Ref | |||
| Tertile 1 | 1.6 (1.0–2.7) | 0.05 | 0.5 (0.1–1.6) | 0.23 | 1.6 (0.9–2.9) | 0.09 |
| Tertile 2 | 1.3 (0.8–2.1) | 0.32 | 0.3 (0.1–1.0) | 0.05 | 1.3 (0.7–2.4) | 0.40 |
| Tertile 3 | 1.5 (0.9–2.4) | 0.13 | 0.4 (0.2–1.2) | 0.09 | 1.6 (0.8–3.5) | 0.21 |
Models contain all predictors in the table.